Learn how a consultancy strengthened its market research by engaging with 30 oncology KOLs sourced...
Posted by
Ryan Chapa |
Find out how a professional services firm conducting market research on behalf of a pharmaceutical company used expert engagements to develop a go-to-market strategy.
The challenge
A leading professional services firm conducting market research on behalf of a global pharmaceutical company needed to better understand the key drivers and barriers to treatments of rare liver disease.
They needed to gain key industry insights to inform a go-to-market strategy they were developing for their client’s new therapy.
The solution
To support the customer with real-world expertise, we connected them with key opinion leaders (KOLs) and prescribers specializing in rare liver diseases.
Using our AI-driven expert matching, we custom-recruited specialists precisely aligned with the project’s requirements. This enabled qualitative interviews across five countries and a diverse range of expert profiles, including:
1. Oncologists
2. Gastroenterologists
3. Hepatologists
4. Surgeons
5. Interventional radiologists
The outcome
We connected the customer with 77 KOLs and prescribers across the US, Germany, China, Japan, and France.
With these expert perspectives, the customer developed a market-ready strategy, equipping their pharma client with the confidence to launch their new rare liver disease therapy successfully.
Some of the high-quality experts we sourced for the customer included:
| Chief of Gastroenterology at a university school of medicine (Japan) | Associate Professor of Radiology at a university hospital (USA) |
| Chief Hepatologist at a university hospital (China) | Gastrointestinal surgeon at a private clinic (France) |
| Head of Visceral Oncology at a cancer center (Germany) |
